All Companies

LLYCongressional Stock Trades

Eli Lilly & Co.

Pharmaceutical Preparations

Congressional stock trades in Eli Lilly & Co. (LLY) from House and Senate STOCK Act filings. See which members of Congress bought or sold, disclosed amounts, and filing dates.

Total Trades

53

Politicians Trading

22

Last Traded

Jul 10, 2026

Trading History

PoliticianNotifiedTradedTypeAmountChange
Julie JohnsonDJan 15, 2026Dec 18, 2025Sell$1,001 - $15,000+9.09%
Julie JohnsonDDec 11, 2025Nov 13, 2025Sell$1,001 - $15,000+12.72%
Val T. HoyleDOct 10, 2025Sep 23, 2025Sell$1,001 - $15,000+54.35%
Val T. HoyleDSep 12, 2025May 6, 2025Sell$1,001 - $15,000+48.74%
Julie JohnsonDSep 11, 2025Aug 14, 2025Sell$1,001 - $15,000+68.45%
Jonathan L. JacksonDAug 25, 2025May 21, 2025Sell$1,001 - $15,000+59.04%
Jonathan L. JacksonDJul 14, 2025Jun 3, 2025Sell$15,001 - $50,000+53.56%
Josh GottheimerDJun 11, 2025May 13, 2025Sell$1,001 - $15,000+54.54%
Gilbert Ray Cisneros, Jr.DJun 6, 2025May 30, 2025Sell$1,001 - $15,000+56.29%
Josh GottheimerDMay 14, 2025Apr 9, 2025Sell$1,001 - $15,000+52.97%
Julie JohnsonDMay 14, 2025Apr 7, 2025Sell$1,001 - $15,000+59.30%
Josh GottheimerDApr 10, 2025Mar 10, 2025Sell$1,001 - $15,000+38.95%
Josh GottheimerDMar 6, 2025Feb 19, 2025Sell$1,001 - $15,000+32.97%
Josh GottheimerDFeb 10, 2025Jan 8, 2025Sell$1,001 - $15,000+46.46%

Price History

About Eli Lilly & Co.

Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.